References
- Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014 Feb;23(2):121–130.
- Sotelo JL, Musselman D, Nemeroff C. The biology of depression in cancer and the relationship between depression and cancer progression. Int Rev Psychiatry. 2014 Feb;26(1):16–30.
- Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011 Feb;12(2):160–174.
- Jia Y, Li F, Liu YF, et al. Depression and cancer risk: a systematic review and meta-analysis. Public Health. 2017 Aug;149:138–148.
- Colleoni M, Mandala M, Peruzzotti G, et al. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet. 2000 Oct 14;356(9238):1326–1327.
- Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010 Nov;40(11):1797–1810.
- Williams SZ, Chung GS, Muennig PA. Undiagnosed depression: A community diagnosis. SSM Popul Health. 2017;3:633–638.
- Saracino RM, Weinberger MI, Roth AJ, et al. Assessing depression in a geriatric cancer population. Psychooncology. 2017 Oct;26(10):1484–1490.
- De Berardis D, Fornaro M, Orsolini L, et al. Alexithymia and suicide risk in psychiatric disorders: a mini-review. Front Psychiatry. 2017;8:148.
- Engel-Yeger B, Muzio C, Rinosi G, et al. Extreme sensory processing patterns and their relation with clinical conditions among individuals with major affective disorders. Psychiatry Res. 2016 Feb;28(236):112–118.
- [ cited 2019 Dec 30]. https://www.canada.ca/en/health-canada/services/food-nutrition/food-nutrition-surveillance/health-nutrition-surveys/canadian-community-health-survey-cchs.html
- [ cited2019 Dec 31]. https://www.statcan.gc.ca/eng/survey/household/3226
- Hinz A, Mehnert A, Kocalevent R-D, et al. Assessment of depression severity with the PHQ-9 in cancer patients and in the general population. BMC Psychiatry. 2016;16:22.
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606–613.
- Abdel-Rahman O. Socioeconomic predictors of suicide risk among cancer patients in the United States: A population-based study. Cancer Epidemiol. 2019 Dec;63:101601.
- Public Health Agency of Canada. Health Status of Canadians.2016. Ottawa, ON: Public Health Agency of Canada; 2016. p. 1–62.
- Domogauer JD, Colangelo N, Aggarwal R. Study of total and undiagnosed depression in a cancer patient population at an urban cancer center. Int J Radiat Oncol Biol Phys. 2017;99(2):S10.
- Abdel-Rahman O. Depression and suicidal ideation among cancer patients in the United States; a population-based study. JCO Oncol Pract. 2020. DOI:10.1200/JOP.19.00497.
- Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71.
- Cheung AH, Dewa CS. Canadian community health survey: major depressive disorder and suicidality in adolescents. Healthc Policy. 2006;2(2):76–89.
- Pasquini M, Biondi M. Depression in cancer patients: a critical review. Clin Pract Epidemiol Ment Health. 2007;3: 2-2.
- Mulick A, Walker J, Puntis S, et al. Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials. Lancet Psychiatry. 2018;5(4):321–326.
- Prisnie JC, Fiest KM, Coutts SB, et al. Validating screening tools for depression in stroke and transient ischemic attack patients. Int J Psychiatry Med. 2016 Apr;51(3):262–277.
- Pitman A, Suleman S, Hyde N, et al. Depression and anxiety in patients with cancer. Bmj. 2018 Apr;25(361):k1415.
- Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American society of clinical oncology guideline adaptation. J Clin Oncol. 2014 May 20;32(15):1605–1619.
- Wakefield CE, Butow PN, Aaronson NA, et al. Patient-reported depression measures in cancer: a meta-review. Lancet Psychiatry. 2015 Jul;2(7):635–647.
- Nonzee NJ, Ragas DM, Ha Luu T, et al. Delays in cancer care among low-income minorities despite access. J Women’s Health (15409996). 2015;24(6):506–514.
- Ramondetta LM, Meyer LA, Schmeler KM, et al. Avoidable tragedies: disparities in healthcare access among medically underserved women diagnosed with cervical cancer. Gynecol Oncol. 2015;139(3):500–505.
- Oduro C, Connor SE, Litwin MS, et al. Barriers to prostate cancer care: affordable care is not enough. Qual Health Res. 2013 Mar;23(3):375–384.
- Canadian Partnership Against Cancer. The 2016 cancer system performance report [Internet]. Toronto, ON: Canadian Partnership Against Cancer; 2016 [cited 2018 Nov 15]. Available from: http://www.systemperformance.ca/report/2016-cancer-system-performance-report/
- Abdel-Rahman O. Patient-reported cognitive and functional impairments among older canadians with cancer; A population-based study. J Pain Symptom Manage. 2020 Aug 5. DOI:10.1016/j.jpainsymman.2020.07.038.
- Bubis LD, Davis L, Mahar A, et al. Symptom burden in the first year after cancer diagnosis: an analysis of patient-reported outcomes. J Clin Oncol. 2018;36(11):1103–1121.